Claryx

Claryx is dedicated to stopping infections before they start through genomic biosurveillance. Using proprietary technology that reduces certain sequencing costs by more than twentyfold. By genetically linking environmental detections to patient cases, Claryx enables hospitals to pinpoint outbreaks early, intervene decisively, and anticipate emerging threats before they escalate – improving outcomes while reducing costs.